Xiaofei Xin
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Baiting-enhanced extravasation of lipid nanoparticles for targeted co-delivery of decitabine and siTNF-α to the bone marrow niche in leukemia therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 10, 2025
Engineered cyclodextrin-protein domain interface modulation and application in nanoscale delivery systems development for therapeutic proteins.
Journal: Colloids and surfaces. B, Biointerfaces
Published: June 15, 2025
Catch-to-Amplify Nanoparticles with Bacteria Surface for Sequential Mucosal Immune Activation for Acute Myeloid Leukemia Therapy.
Journal: ACS nano
Published: April 09, 2025
Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis.
Journal: Biomedicines
Published: January 23, 2025
Notch1 siRNA and AMD3100 Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Biomedicines
Published: December 20, 2024
Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 19, 2024
Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 02, 2024
Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 12, 2023
Disease-specific corona mediated co-delivery of MTX and siRNA-TNFα by a polypeptide nanoplatform with antigen-scavenging functions in psoriasis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 16, 2023
Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 23, 2023
Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies.
Journal: Pharmacology & therapeutics
Published: June 14, 2023
Last Updated: 09/26/2026